Menu

Investors

Investor Relations

Akebia Therapeutics

Since our founding in 2007, Akebia (Nasdaq: AKBA) has been focused on achieving better outcomes for people with kidney disease. We are a leader in the renal community – a fully integrated biopharmaceutical company with capabilities ranging from research through commercialization.

We have a portfolio focused on addressing significant unmet needs for people living with kidney disease.

 

OUR MEDICINE

RESEARCH & DEVELOPMENT

Events & Presentations

June 9, 2022 at 10:30 AM EDT

May 24, 2022 at 7:00 AM EDT

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Presentation
Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us